Vynleads (VYND) Revenue (2020 - 2022)

Vynleads' (VYND) quarterly Revenue came in at $49.0 in Q2 2022, down 75.86% year-on-year from $203.0 in Q2 2021, and down 75.86% on a QoQ basis from $203.0 in Q2 2021.

Vynleads (VYND) Revenue (2020 - 2022) Analysis & Trends

Vynleads (VYND) has 3 years of Revenue data on file, last reported at $49.0 in Q2 2022.

  • On a quarterly basis, Revenue fell 75.86% year-over-year to $49.0 in Q2 2022; TTM through Mar 2023 was $49.0, a N/A change from a year earlier, with the FY2022 full-year figure at $49.0, down 89.88% from the prior year.
  • Revenue for Q2 2022 stood at $49.0, down from $203.0 in the prior quarter.
  • Over the last five years, Revenue for VYND reached as high as $23388.0 in Q1 2020 and fell as low as $49.0 in Q2 2022.
  • Historically, Revenue has averaged $6970.7 across 3 years, with a median of $770.0 in 2020.
  • Across the five-year window, Revenue plunged 98.8% in 2021 and plunged 75.86% in 2022, its largest moves.
  • Year by year, Revenue stood at $770.0 in 2020, then sank by 73.64% to $203.0 in 2021, then plunged by 75.86% to $49.0 in 2022.
  • Per Business Quant data, the three most recent Revenue figures were $49.0 in Q2 2022, $203.0 in Q2 2021, and $281.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn 882.95 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 3.61 Bn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn 354.64 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn 150.84 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn 182.31 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn 837.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 313.87 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn 145.37 Mn
9 Privia Health 3.10 Bn 2.73 Bn - 603.85 Mn
10 Vynleads 7.51 Mn 7.51 Mn -2,028.00 -

Historic Data

Download Data
DateValue
Jun 30, 2022 49.00
Jun 30, 2021 203.00
Mar 31, 2021 281.00
Dec 31, 2020 770.00
Sep 30, 2020 8,379.00
Jun 30, 2020 15,725.00
Mar 31, 2020 23,388.00